Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed375%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears

NCT01788683
completednot_applicable

Regenexx™ SD Versus Exercise Therapy for ACL Tears

NCT01850758
completednot_applicable

Regenexx™ SD Versus Exercise Therapy for Treatment of Knee Osteoarthritis With Historical Comparison to TKA

NCT02034032
terminated

A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment

NCT02370823

Clinical Trials (4)

Showing 4 of 4 trials
NCT01788683Not Applicable

Regenexx™ SD Versus Exercise Therapy for Rotator Cuff Tears

Completed
NCT01850758Not Applicable

Regenexx™ SD Versus Exercise Therapy for ACL Tears

Completed
NCT02034032Not Applicable

Regenexx™ SD Versus Exercise Therapy for Treatment of Knee Osteoarthritis With Historical Comparison to TKA

Completed
NCT02370823

A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment

Terminated

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4